Detalhe da pesquisa
1.
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.
Clin Microbiol Rev
; 35(3): e0022721, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35311552
2.
Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova.
Emerg Infect Dis
; 29(5): 1046-1050, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081601
3.
Emergence of bedaquiline resistance in a high tuberculosis burden country.
Eur Respir J
; 59(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503982
4.
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes.
Eur Respir J
; 60(3)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169026
5.
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing.
Clin Infect Dis
; 73(7): 1194-1202, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33900387
6.
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country.
Eur Respir J
; 57(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33334942
7.
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
Eur Respir J
; 58(3)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33574078
8.
Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future.
Respiration
; 100(9): 843-852, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34058739
9.
(Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review.
Clin Microbiol Infect
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663653
10.
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
Nat Med
; 30(3): 896-904, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365949
11.
Long-term treatment outcomes in patients with multidrug-resistant tuberculosis.
Clin Microbiol Infect
; 29(6): 751-757, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842637
12.
Update on the diagnosis of tuberculosis.
Clin Microbiol Infect
; 2023 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490968
13.
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard.
Clin Microbiol Infect
; 29(12): 1605.e1-1605.e4, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689265
14.
Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis.
ACS Infect Dis
; 8(7): 1303-1315, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763439
15.
Correction: Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis.
PLoS One
; 16(2): e0247693, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606851
16.
Seroprevalence of Aspergillus-Specific IgG Antibody among Mozambican Tuberculosis Patients.
J Fungi (Basel)
; 7(8)2021 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34436134
17.
WNT6/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis.
J Clin Invest
; 131(16)2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255743
18.
Perspectives for systems biology in the management of tuberculosis.
Eur Respir Rev
; 30(160)2021 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039674
19.
Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis.
PLoS One
; 15(9): e0238619, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956395
20.
Perspective for Precision Medicine for Tuberculosis.
Front Immunol
; 11: 566608, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33117351